Stanford's VirtualBiotech puts tens of thousands of AI scientist agents in Science, NYT reports
StanfordAILab · x · 2026-09-22
Stanford's VirtualBiotech research, led by James Zou, is published in Science and covered by the New York Times. The system deploys tens of thousands of AI scientist agents collaborating across the full drug discovery and development pipeline, from target discovery to clinical trial design.
The team recalls a 2024 experiment where human scientist John Pak tasked AI agents with redesigning part of a Covid-19 vaccine. The agents brainstormed in parallel conversations, often duplicating themselves and debating the same topic in five threads at once. Within days they produced dozens of novel proteins theoretically capable of binding new Covid variants.
The paper offers a blueprint for "agentic R&D," positioning AI agents as co-scientists that could meaningfully speed up biomedical research.
More from Apps
- Loom founder launches Roma 2.0, a shared to-do list that orchestrates AI agents — thetripathi58 · 2026-11-12
- Google Labs launches Tabletop, an AI experiment for on-demand shared group spaces — GoogleLabs · 2026-11-12
- Llama app adds simultaneous voice, image and video input, running locally on LFM3-Omni — mervenoyann · 2026-11-12
- Google Labs launches Tabletop, an AI experiment that builds custom shared spaces on demand — GoogleLabs · 2026-11-12
- Developer builds VladOS, a personal life dashboard, by just describing it to an AI agent — haltakov · 2026-11-12
- Typeless partners with Anker on soundcore Work wearable mic to replace typing — CurieuxExplorer · 2026-11-11